Pharmaceutical Business review

Sannova requests partial change in Neuzym label

Neuzym is egg white lysozyme preparation.

The application holds good to Neuzym Series’ all six products, pharmalive.com reported.

The portfolio of products includes Neuzym Tablets (10 mg, 30 mg and 90 mg), Neuzym Granules (10%), Neuzym Fine Granules

(20%), and Neuzym Syrup (0.5%).

The company intends to make changes to the dosage and administration besides removing alveolar pyorrhea and other conditions as approved indications for the product.